EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Understanding the interconnected roles of gut microbiota and metabolomic profiles in alcoholic liver disease pathophysiology and their potential for innovative treatment strategies

Jeyakumar Balakrishnan, Suganya Kannan, Ganeshbala Arivazhagan, Niranjjan Ramachandran, Vanitha Gnanasoundran Sundarasamy

Medicine in Microecology · 2025-12 · 26 · 100154

DOI: 10.1016/j.medmic.2025.100154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine in Microecology, 2025-12. Verfasst von Jeyakumar Balakrishnan und 4 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vinayaka Mission's Research Foundation, NITTE University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcoholic liver disease (ALD) remains a major global health burden driven by chronic alcohol consumption and characterized by progressive liver injury, inflammation, and fibrosis. A growing body of evidence highlights the central role of the gut-liver axis in ALD pathogenesis, where alcohol-induced dysbiosis and intestinal barrier disruption facilitate the translocation of bacterial endotoxins such as lipopolysaccharides (LPS) into the liver. These microbial products activate Kupffer cells via Toll-like receptor 4 (TLR4) signaling, triggering inflammatory cascades, oxidative stress, and hepatic stellate cell activation, thereby promoting fibrogenesis. Dysregulated bile acid metabolism, impaired FXR and TGR5 signaling, and depletion of beneficial microbial metabolites such as short-chain fatty acids (SCFAs) further contribute to liver damage. Advances in metabolomics have uncovered distinct microbial and host-derived metabolic signatures linked to disease severity, including SCFA depletion, elevated trimethylamine-N-oxide (TMAO), and bile acid imbalances. Precision interventions targeting the gut microbiota—such as probiotics, prebiotics, synbiotics, and microbial metabolite supplementation—are showing promise in modulating gut-liver interactions and mitigating ALD progression. Furthermore, the integration of multi-omics datasets with artificial intelligence (AI)-driven models is paving the way for personalized treatment strategies based on individual microbiome-metabolome profiles. This review consolidates current insights into ALD pathogenesis, the gut-liver axis, and emerging microbiota-centered precision therapies that are reshaping the future of ALD management. • Alcohol disrupts gut-liver axis causing microbial dysbiosis and liver injury. • Microbial metabolites serve as biomarkers and therapy targets in ALD treatment. • AI-driven multi-omics integration enables precision medicine in ALD therapy. • Precision probiotics and prebiotics restore gut homeostasis in ALD patients. • ALD significantly contributes to global liver morbidity, necessitating action.

Förderung

  • Vinayaka Mission's Research Foundation
  • NITTE University

Zitieren

APA

Balakrishnan, J., Kannan, S., Arivazhagan, G., Ramachandran, N., & Sundarasamy, V. G. (2025). Understanding the interconnected roles of gut microbiota and metabolomic profiles in alcoholic liver disease pathophysiology and their potential for innovative treatment strategies. Medicine in Microecology, 26, 100154. https://doi.org/10.1016/j.medmic.2025.100154

Vancouver

Balakrishnan J, Kannan S, Arivazhagan G, Ramachandran N, Sundarasamy VG. Understanding the interconnected roles of gut microbiota and metabolomic profiles in alcoholic liver disease pathophysiology and their potential for innovative treatment strategies. Medicine in Microecology. 2025;26:100154. doi:10.1016/j.medmic.2025.100154

BibTeX
@article{Balakrishnan2025,
  author = {Balakrishnan, Jeyakumar and Kannan, Suganya and Arivazhagan, Ganeshbala and Ramachandran, Niranjjan and Sundarasamy, Vanitha Gnanasoundran},
  title = {Understanding the interconnected roles of gut microbiota and metabolomic profiles in alcoholic liver disease pathophysiology and their potential for innovative treatment strategies},
  journal = {Medicine in Microecology},
  year = {2025},
  volume = {26},
  pages = {100154},
  doi = {10.1016/j.medmic.2025.100154}
}
Kostenlos starten →